The experimental anti-inflammatory therapy brensocatib was generally well tolerated in adults with cystic fibrosis (CF), according to data from…
Articles by Marisa Wexler, MS
The Cystic Fibrosis Foundation has made an additional $3 million investment in Recode Therapeutics to support clinical development of…
The Unity Fetal Risk Screen, a test that uses a pregnant person’s blood to evaluate the fetus’s risk of…
A trio of scientists is being honored for research contributions that helped lead to the development of Trikafta, a…
The Cystic Fibrosis Foundation is investing up to €6.5 million (about $7.6 million) to support the development of virus-based…
SPL84, an investigational inhalation therapy designed to treat cystic fibrosis (CF) caused by a specific mutation called 3849+10 kb…
The first participants have been dosed in a clinical trial that’s testing some of Sionna Therapeutics’ investigational treatments for…
The U.S. Food and Drug Administration (FDA) has granted two new designations to CMTX-101, an antibody-based therapy Clarametyx Biosciences…
Grants that provide financial assistance for nutrition may help people with cystic fibrosis (CF) maintain a healthy body weight,…
Men with cystic fibrosis (CF) are generally knowledgeable about how their disease affects fertility, but they still want to…